Guy; R. Kiplin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guy; R. Kiplin.The latest application filed is for "methods and compositions of inhibiting dcn1-ubc12 interaction".

Company Profile

3.11.14

Guy; R. Kiplin - Memphis TN
Guy; R. Kiplin - Concord CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for the prevention and treatment of hearing loss Grant 11,446,308 - Zuo , et al. September 20, 2	2022-09-20
Methods and compositions of inhibiting DCN1-UBC12 interaction Grant 11,116,757 - Min , et al. September 14, 2	2021-09-14
Methods And Compositions Of Inhibiting Dcn1-ubc12 Interaction App 20210069172 - MIN; Jaeki ; et al.	2021-03-11
Methods And Compositions For The Prevention And Treatment Of Hearing Loss App 20200179397 - Zuo; Jian ; et al.	2020-06-11
Aryl-substituted imidazoles Grant 10,647,702 - Guy , et al.	2020-05-12
Methods and compositions of inhibiting DCN1-UBC12 interaction Grant 10,525,048 - Min , et al. J	2020-01-07
Aryl-substituted Imidazoles App 20190345141 - Guy; R. Kiplin ; et al.	2019-11-14
Aryl-substituted Imidazoles App 20180291004 - Guy; R. Kiplin ; et al.	2018-10-11
Methods And Compositions Of Inhibiting Dcn1-ubc12 Interaction App 20180256558 - MIN; Jaeki ; et al.	2018-09-13
Methods And Compositions For The Prevention And Treatment Of Hearing Loss App 20180161340 - Zuo; Jian ; et al.	2018-06-14
Aryl-substituted imidazoles Grant 9,822,100 - Guy , et al. November 21, 2	2017-11-21
Aryl-substituted Imidazoles App 20160297800 - Guy; R. Kiplin ; et al.	2016-10-13
Aryl-substituted imidazoles Grant 9,266,860 - Guy , et al. February 23, 2	2016-02-23
Aryl-substituted Imidazoles App 20130345237 - Guy; R. Kiplin ; et al.	2013-12-26
Compounds Having Activity in Increasing Ion Transport by Mutant-CFTR and Uses Thereof App 20120101143 - Verkman; Alan ; et al.	2012-04-26
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof Grant 7,939,558 - Verkman , et al. May 10, 2	2011-05-10
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof Grant 7,696,244 - Verkman , et al. April 13, 2	2010-04-13
Small molecule inhibition of a PDZ-domain interaction Grant 7,601,750 - Guy , et al. October 13, 2	2009-10-13
Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof App 20080319008 - Verkman; Alan ; et al.	2008-12-25
Small molecule inhibition of a PDZ-domain interaction App 20080021082 - Guy; R. Kiplin ; et al.	2008-01-24
Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof App 20070265316 - Verkman; Alan ; et al.	2007-11-15
Small molecule inhibition of a PDZ-domain interaction Grant 7,141,600 - Guy , et al. November 28, 2	2006-11-28
Small molecule inhibition of a PDZ-domain interaction App 20050043385 - Guy, R. Kiplin ; et al.	2005-02-24

Company Registrations

NCAGE Code	4CDM3	GUY R KIPLIN
CAGE Code	4CDM3	GUY, R KIPLIN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.